If you liked this article you might like

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers
Today's Weak On High Volume Stock: SciClone Pharmaceuticals (SCLN)
SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock
Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan